Abdominal Aortic Aneurysms: Background and Pathophysiology
The most relevant curriculum items are "Recalls/describes the morbidity and mortality associated with vascular surgery" and "Explains the preoperative management of the patient with atherosclerotic disease".
An abdominal aortic aneurysm (AAA) is a permanent dilatation of the abdominal aorta to >3cm, or >1.5 times its normal diameter
The normal aortic diameter is ~2cm, and is smaller in women and some ethnic groups, so a fixed 3cm threshold may under-diagnose AAA in these groups
AAAs are classified by their relationship to the renal arteries
Infra-renal (the large majority)
Juxta-renal
Para-renal
Supra-renal
Anything above an infra-renal aneurysm is termed a 'complex' AAA, which has implications for both the level of cross-clamping in open repair and the type of graft needed for EVAR
Epidemiology
The incidence of AAA has fallen markedly over recent decades, largely as a result of reduced smoking
In the UK screening programme, prevalence in 65-year-old men is now <1%, having been 1.3% in 2013
AAA is up to four times less common in women, though women who do develop an AAA have:
A higher risk of rupture for any given diameter
Higher mortality following both elective and emergency repair
Ruptured AAA still accounts for around 6,000 deaths per year in England and Wales
Risk factors
Risk factors for AAA development
Risk factors for AAA rupture
Smoking (the strongest risk factor; OR >3)
Increasing diameter
Male sex
Rapid rate of expansion
Increasing age (>65yrs)
Female sex
Family history (heritability up to 70% in twin studies)
Current smoking
Hypertension and hyperlipidaemia
Hypertension
Coronary, cerebrovascular or peripheral vascular disease
White ethnicity
Connective tissue disease e.g. Marfan's, vascular Ehlers-Danlos
Smoking is the most important modifiable risk factor for AAA formation, growth and rupture
Diabetes is curiously protective; the risk of developing an AAA is roughly halved, and aneurysms grow more slowly
Pathophysiology
AAA is a degenerative disease of the aortic wall, primarily affecting the tunica media
Within the aneurysmal segment there are fewer elastin and collagen fibres, and those which remain have poor quality cross-links
Wall strength is further compromised by:
Chronic inflammatory cell infiltration of the wall
Increased protease activity, notably matrix metalloproteinases and elastase, leading to elastin and collagen breakdown
Loss of vascular smooth muscle cells
Intraluminal mural thrombus, which is metabolically active and promotes local hypoxia, plasminogen activation and further proteolysis
As the aneurysm enlarges, wall tension rises (Laplace's law; T = P × r), which promotes further dilatation; a self-perpetuating cycle
Natural history
Most small AAAs grow progressively although growth is faster with a larger diameter and continued smoking, and slower in those with diabetes
The strongest predictors of rupture are maximum diameter and rate of expansion
Rupture risk in small AAAs is low; it is estimated as <1% within 1 year for a 5cm AAA, within 4 years for a 4cm AAA and within 8 years for a 3cm AAA
Women have a higher rupture rate than men with aneurysms of the same size
The risk rises steeply once the aneurysm exceeds the repair threshold:
Diameter (untreated large AAA)
Annual rupture rate
5.5 - 6.0cm
3.5%
6.1 - 7.0cm
4.1%
>7.0cm
6.3%
Diagnosis
Intact AAAs are usually clinically silent and found incidentally or on screening
Symptoms, if present, include abdominal or back pain, tenderness over the aneurysm, or features of compression of adjacent structures
Ultrasound is the first-line tool for diagnosis and surveillance; it is cheap, non-invasive and has a sensitivity and specificity approaching 100%
CT angiography is used for treatment planning once the repair threshold is reached, and for the diagnosis of rupture
Screening
The NHS AAA Screening Programme (introduced 2009) offers a single abdominal ultrasound to men in the year they turn 65; older men may self-refer
Women are not routinely screened, as the low prevalence makes it neither cost-effective nor suitably mortality-reducing
NICE suggest considering an aortic ultrasound in women ≥70yrs with risk factors (e.g. COPD, smoking, vascular disease, hypertension, hyperlipidaemia or family history)
Underwent elective repair when the aneurysm diameter reached 5.5cm
Population screening reduces aneurysm-related mortality by around 50% and is cost-effective
Surveillance
Small aneurysms detected by the NHS programme are followed up with ultrasound at intervals determined by size:
Aortic diameter
NHS screening programme action
<3.0cm
Normal; discharged
3.0 - 4.4cm (small)
Annual ultrasound
4.5 - 5.4cm (medium)
3-monthly ultrasound
≥5.5cm (large)
Urgent referral to a vascular surgeon
All patients with an AAA should receive cardiovascular risk reduction, as they are far more likely to die from a cardiovascular event than from their aneurysm
Smoking cessation, which slows aneurysm growth and reduces rupture risk
Blood pressure control
Statin therapy
Antiplatelet therapy e.g. low-dose aspirin
Lifestyle advice including exercise and a healthy diet
No drug has been shown to slow aneurysm growth; trials of doxycycline, ACE-inhibitors, β-blockers, ARBs and others have all been negative
Exercise (and sexual activity) need not be restricted in patients with a small AAA
An AAA is not a contraindication to fluoroquinolone antibiotics, despite earlier regulatory warnings
When to repair
Repair is considered when the risk of rupture outweighs the risk of surgery; the generally accepted thresholds are:
Men with an asymptomatic AAA ≥5.5cm
Women with an asymptomatic AAA ≥5.0cm (reflecting their higher rupture risk)
A symptomatic AAA of any size
Rapid growth e.g. >1cm in 1 year in an AAA >4cm
There is no long-term survival benefit to early repair of AAAs of 4.0 - 5.5cm, according to the
UKSAT (1998)
and
ADAM (2000) trials
Patients reaching the threshold should be fast-tracked to vascular review and NICE aim for repair within 8 weeks of referral
Elective repair is not recommended for patients with limited life expectancy, by either open or endovascular means
Open repair or EVAR?
The decision is made in the vascular MDT (vascular surgeon, interventional radiologist and vascular anaesthetist) with the patient, weighing:
Aneurysm anatomy; suitability of the aortic neck and access vessels on CT angiography
Physiological fitness and functional capacity
Life expectancy
Patient preference, including willingness to undergo lifelong surveillance after EVAR
Guidelines differ in emphasis, reflecting the trade-off of lower early mortality with EVAR against greater long-term re-intervention and late rupture
In practice, younger, fitter patients tend to undergo open repair, and older patients with more comorbidity EVAR